scispace - formally typeset
Search or ask a question
Institution

Roussel Uclaf

About: Roussel Uclaf is a based out in . It is known for research contribution in the topics: Alkyl & Alkoxy group. The organization has 1888 authors who have published 2338 publications receiving 36508 citations.
Topics: Alkyl, Alkoxy group, Aryl, Carbon, Carboxylic acid


Papers
More filters
Patent
04 Jan 1994
TL;DR: In this article, a novel process for the preparation of a compound of the formula "STR1" was proposed, where R 1, R 2, R 3 and R 4 are defined in the text.
Abstract: A novel process for the preparation of a compound of the formula ##STR1## wherein R 1 , R 2 , R 3 and R 4 are defined in the text.

8 citations

Patent
14 Nov 1994
TL;DR: In this paper, a method of treating hyperandrogenism in warm-blooded animals comprising administering to warmblooded animals an antiandro genically effective amount of oenotheine B and a process for the preparation of OENOTE B was described.
Abstract: A method of treating hyperandrogenism in warm-blooded animals comprising administering to warm-blooded animals an antiandro genically effective amount of oenotheine B and a process for the preparation of oenotheine B

8 citations

Patent
19 Aug 1988
TL;DR: In this paper, the invention relates to compounds of formula (I): wherein R is either hydrogen or linear, branched or cyclic, saturated or unsaturated wherein R wherein R
Abstract: The invention relates to compounds of formula (I): wherein R is either hydrogen or linear, branched or cyclic, saturated or unsaturated wherein R wherein R

8 citations

Patent
07 Mar 1994
TL;DR: A compound in all racemic or optionally active forms selected from the group consisting of a compound of the formula STR1## where the substituents are defined as in the specification and their non-toxic, pharmaceutically acceptable acid addition salts having anti-anoxic activity and a novel process and intermediates for their preparation.
Abstract: A compound in all racemic or optionally active forms selected from the group consisting of a compound of the formula ##STR1## where the substituents are defined as in the specification and their non-toxic, pharmaceutically acceptable acid addition salts having anti-anoxic activity and a novel process and intermediates for their preparation.

8 citations

Journal ArticleDOI
TL;DR: VPA and all teratogenic analogues, at 3 mM, inhibited neuronal cell aggregation and limb bud chondrocyte differentiation in a manner that exhibited a reasonable correlation with their in vivo teratogenicity.

8 citations


Authors

Showing all 1888 results

NameH-indexPapersCitations
Fernand Labrie11088548308
Lionel H. Opie8451925964
Alain Bélanger7024416469
Michel J. Tremblay5327310485
Pierre Monsan512168049
Samir Z. Zard5057510739
Alejandro Aruffo4712314084
Samuel S.C. Yen47966865
Dominique Maraninchi471888108
Serge Erlinger461528200
Romain Lefebvre402215269
William B. Motherwell393056357
Jean-Pierre Raynaud381045075
André Lemay381144264
Patrick J. Creaven321023435
Network Information
Related Institutions (5)
Merck & Co.
48K papers, 1.9M citations

85% related

Novartis
50.5K papers, 1.9M citations

85% related

Pfizer
37.4K papers, 1.6M citations

84% related

Eli Lilly and Company
22.8K papers, 946.7K citations

84% related

AstraZeneca
23.4K papers, 938.2K citations

82% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20181
20114
20104
20091
20084
20072